Owing to numerous technical and regulatory challenges, outsourcing has become a popular business model for medical device developers; in fact, a number of CMOs presently provide specialized manufacturing services to the innovators in this industry
LONDON, Aug. 22, 2019 /PRNewswire/ -- Roots Analysis has announced the addition of "Medical Device Contract Manufacturing Market, 2019-2030" report to its list of offerings.
More than 100 medical devices were approved by the FDA in 2018, while several are currently being evaluated across more than 9,500 (active) clinical trials, worldwide. Further, increase in aging population, coupled with rise in the prevalence of chronic disorders, are likely to drive the demand for medical devices. Therefore, in order to reduce the overall cost and expedite the time to market, majority of original equipment manufacturers (OEMs) are outsourcing their medical device manufacturing operations to CMOs.
To order this 550+ page report, which features 220+ figures and 220+ tables, please visit this link
Key Market Insights
Over 275 companies offer contract manufacturing services for finished medical device products
The market is dominated by the presence of mid-sized companies (having 200 to 1,000 employees), which represent close to 53% of the competitive landscape. This is followed by small-sized companies (about 23%) and large firms (nearly 15%).
More than 60% of medical device CMOs are based in the US; majority of these CMOs have their manufacturing capabilities established within North America
Examples of such companies include (in alphabetical order, large and very large companies) Biomedical Innovations, Celestica, East West Manufacturing, Flex, Gerresheimer Jabil, Phillips-Medisize, Plexus Röchling Medical and Viant Medical. In fact, the US is presently considered a key hub for medical device contract manufacturing operations. Further, a significant number of players have also established their manufacturing facilities (more than 140) in Asia and other developing countries of the world.
Over 9,500+ clinical trials are evaluating a number of types of medical devices
Of these, around 60% trials are actively recruiting patients. So far, 4 million patients have been enrolled in ongoing / planned trials of medical devices. Interestingly, majority of these patients (more than 1.6 million) were enrolled in the Asia Pacific region, during the period between 2013 and 2019.
150+ mergers and acquisitions inked between 2014 and 2018
The service portfolios of most of the acquired CMOs included medical device manufacturing services (more than 75%), design-related services (52%) and packaging services (14%). Examples of recent acquisitions in this domain include (in reverse chronological order) acquisition of Arcor Laser Services by Cadence (May 2019), ARCH Global Precision by The Jordan Company (April 2019) and Sparton by Cerberus Capital Management (March 2019). In terms of the device types, majority of the acquisitions were made for companies offering services for implants and instruments.
The market opportunity for medical device CMOs is likely to grow at an annualized rate of over 8% till 2030
Presently, medical device contract manufacturing services for cardiovascular disorders represent the dominant revenue generating segment (over 23%) in the overall market, followed by devices for oncological disorders (close to 12%) and CNS disorders (approximately 11%).
To request a sample copy / brochure of this report, please visit this link
Key Questions Answered
- Who are the leading CMOs in the medical device contract manufacturing market?
- Where are the medical device manufacturing facilities located?
- What is the global, installed manufacturing capacity for medical devices?
- What are the key value drivers behind the merger and acquisition activity in the medical device contract manufacturing industry?
- How is the current and future market opportunity likely to be distributed across key market segments?
- What are the opportunities offered by emerging markets for medical device contract manufacturing?
- What are the prevalent trends in medical device contract manufacturing?
- What are the key challenges faced by medical device focused CMOs?
- What is the role of automation in medical device manufacturing?
- Is it possible to optimize the medical device supply chain to achieve cost benefits and ensure product quality?
The USD 126 billion (by 2030) financial opportunity within the medical device contract manufacturing market has been analyzed across the following segments:
- Application areas
- Therapeutic devices
- Diagnostic devices
- Drug delivery devices
- Other devices
- Device class
- Class I medical devices
- Class II medical devices
- Class III medical devices
- Therapeutic areas
- Cardiovascular disorders
- CNS disorders
- Metabolic disorders
- Oncological disorders
- Orthopedic disorders
- Ophthalmic disorders
- Pain disorders
- Respiratory disorders
- Other therapeutic areas
- Key geographical regions
- North America
- Asia Pacific
- Rest of the world
The report also includes information on insights provided by the following industry experts:
- Raghu Vadlamudi (Chief Research and Technology Director, Donatelle)
- Jan Wahlström (President and Chief Executive Officer, Elos Medtech)
The research covers profiles of key players that offer contract manufacturing services for medical devices, featuring an overview of the company, its service portfolio, details on manufacturing facilities, and an informed future outlook.
- Cirtec Medical
- Creganna Medical
- DynaFlex Technologies
- Europlaz Technologies
- I-Tek Medical Technologies
- Keystone Solutions Group
- Modern Medical
- Providence Enterprise
- Riverside Medical Packaging
- Suzhou Jenitek
- Trelleborg Sealing Solutions
For additional details, please visit
You may also be interested in the following titles:
- Vaccine Contract Manufacturing Market (2nd Edition), 2019-2030
- Biopharma Contract Manufacturing Market (3rd Edition), 2019-2030
- Large Volume Wearable Injectors Market (4th Edition), 2018-2030
- Global Autoinjectors Market (2nd Edition), 2018-2030
SOURCE Roots Analysis